Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Monte Rosa Therapeutics, Inc. (GLUE)  
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 61,370,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $ - $
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   Monte Rosa Therapeutics is a biopharmaceutical company. Co. has developed a protein degradation platform, called QuEEN™ (Quantitative and Engineered Elimination of Neosubstrates), to enable its target-centric approach to its molecular glue degraders (MGDs) discovery and development. Co.'s QuEEN platform enables it to identify protein targets and associated MGD product candidates that are designed to eliminate therapeutically-relevant proteins. Co.'s primary candidate, MRT-2359, is an orally bioavailable degrader of the translation termination factor protein GSPT1 in development initially for use in the treatment of cancers overexpressing one of the Myc family genes (c-Myc, N-Myc and L-Myc).


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 10,000 10,000 10,000 10,000
Total Buy Value $58,383 $58,383 $58,383 $58,383
Total People Bought 1 1 1 1
Total Buy Transactions 1 1 1 1
Total Shares Sold 2,062 2,062 1,861,346 1,862,553
Total Sell Value $9,174 $9,174 $12,306,375 $12,311,251
Total People Sold 1 1 2 2
Total Sell Transactions 1 1 8 9
End Date 2025-03-16 2024-12-13 2024-06-14 2023-06-15

   
Records found: 53
  Page 1 of 3  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Dunn Edmund Principal Accounting Officer   •       –      –    2025-06-03 4 S $4.45 $9,174 D/D (2,062) 23,732     -
   Leo Chandra P.   –       •      –    2025-03-24 4 B $5.84 $58,383 D/D 10,000 10,000 0.01     -
   Dunn Edmund Principal Accounting Officer   •       –      –    2025-01-02 4 A $0.00 $0 D/D 11,850 25,794     -
   Nickson Philip Chief Business & Legal Officer   •       –      –    2025-01-02 4 A $0.00 $0 D/D 36,000 36,000     -
   Janku Filip Chief Medical Officer   •       –      –    2025-01-02 4 A $0.00 $0 D/D 36,000 45,189     -
   Warmuth Markus President & CEO   •       •      –    2025-01-02 4 A $0.00 $0 D/D 128,000 544,538     -
   Townson Sharon Chief Scientific Officer   •       –      –    2025-01-02 4 A $0.00 $0 D/D 36,000 36,000     -
   Champoux Jennifer Chief Operating Officer   •       –      –    2025-01-02 4 A $0.00 $0 D/D 30,000 30,000     -
   Versant Vantage I Gp-Gp, Llc   –       –       •   2024-10-29 4 S $9.08 $621,801 I/I (67,905) 1,573,453     -
   Versant Vantage I Gp-Gp, Llc   –       –       •   2024-10-28 4 D $0.00 $0 I/I (415,535) 0     -
   Versant Vantage I Gp-Gp, Llc   –       –       •   2024-10-28 4 A $0.00 $0 I/I 48,945 5,454     -
   Versant Vantage I Gp-Gp, Llc   –       –       •   2024-10-28 4 D $0.00 $0 D/D (1,019,867) 4,079,469     -
   Versant Vantage I Gp-Gp, Llc   –       –       •   2024-10-28 4 S $9.66 $869,240 I/I (89,990) 2,007,948     -
   Versant Vantage I Gp-Gp, Llc   –       –       •   2024-09-20 4 S $6.53 $7,395,203 D/D (1,132,566) 5,099,336     -
   Versant Vantage I Gp-Gp, Llc   –       –       •   2024-09-13 4 S $6.16 $57,100 D/D (9,269) 6,231,902     -
   Versant Vantage I Gp-Gp, Llc   –       –       •   2024-09-12 4 S $6.00 $96,309 D/D (16,047) 6,241,171     -
   Versant Vantage I Gp-Gp, Llc   –       –       •   2024-09-11 4 S $6.00 $3,251,382 D/D (541,897) 6,257,218     -
   Dunn Edmund Principal Accounting Officer   •       –      –    2024-07-05 4 S $3.83 $6,166 D/D (1,610) 13,944     -
   Dunn Edmund Principal Accounting Officer   •       –      –    2024-06-03 4 S $4.04 $4,876 D/D (1,207) 15,554     -
   Dunn Edmund Principal Accounting OfficerOf   •       –      –    2023-08-08 3 IO $0.00 $0 D/D 0 16,761     -
   Walker Paul Edward 10% Owner   –       –       •   2021-06-28 4 B $19.00 $19,950,000 I/I 1,050,000 7,692,298 1.5     -
   Walker Paul Edward 10% Owner   –       –       •   2021-06-28 4 A $0.00 $0 I/I 6,642,298 6,642,298     -
   Mathers Edward T 10% Owner   –       –       •   2021-06-28 4 B $19.00 $19,950,000 I/I 1,050,000 7,692,298 1.5     -
   Mathers Edward T 10% Owner   –       –       •   2021-06-28 4 A $0.00 $0 I/I 6,642,298 6,642,298     -
   Sandell Scott D 10% Owner   –       –       •   2021-06-28 4 B $19.00 $19,950,000 I/I 1,050,000 7,692,298 1.5     -

  53 Records found
  1  2  3   
  Page 1 of 3
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed